{"credit":[{"email":"joachim.eichborn@charite.de","name":"Joachim von Eichborn","typeEntity":"Person","typeRoles":["Primary contact"]},{"email":"robert.preissner@charite.de","name":"Robert Preissner","typeEntity":"Person","typeRoles":["Primary contact"]}],"documentation":[{"type":"GENERAL","url":"http://bioinformatics.charite.de/promiscuous/index.php?site=about"}],"function":[{"operation":[{"term":"Protein interaction network analysis","uri":"http://edamontology.org/operation_0276"},{"term":"Protein-protein interaction prediction","uri":"http://edamontology.org/operation_2464"},{"term":"Text mining","uri":"http://edamontology.org/operation_0306"},{"term":"Pathway or network prediction","uri":"http://edamontology.org/operation_3439"}]}],"labels":{"language":["Java"],"operatingSystem":["Linux","Windows","Mac"],"toolType":["Database portal"],"topic":[{"term":"Protein interactions","uri":"http://edamontology.org/topic_0128"},{"term":"Small molecules","uri":"http://edamontology.org/topic_0154"},{"term":"Molecular interactions, pathways and networks","uri":"http://edamontology.org/topic_0602"},{"term":"Medicinal chemistry","uri":"http://edamontology.org/topic_0209"},{"term":"Drug metabolism","uri":"http://edamontology.org/topic_3375"}]},"publication":[{"abstract":"The procedure of drug approval is time-consuming, costly and risky. Accidental findings regarding multispecificity of approved drugs led to block-busters in new indication areas. Therefore, the interest in systematically elucidating new areas of application for known drugs is rising. Furthermore, the knowledge, understanding and prediction of so-calledoff-target effects allow a rational approach to the understanding of side-effects. With PROMISCUOUS we provide an exhaustive set of drugs (25 000), including withdrawn or experimental drugs, annotated with drug-protein and protein-protein relationships (21 500/104 000) compiled from public resources via text and data mining including manual curation. Measures of structural similarity for drugs as well as known side-effects can be easily connected to protein-protein interactions to establish and analyse networks responsible for multi-pharmacology. This network-based approach can provide a starting point for drug-repositioning. PROMISCUOUS is publicly available at http://bioinformatics.charite.de/ promiscuous. Â© The Author(s) 2010.","authors":["Von Eichborn J.","Murgueitio M.S.","Dunkel M.","Koerner S.","Bourne P.E.","Preissner R."],"cit_count":132,"journal":"Nucleic Acids Research","pmid":"21071407","title":"PROMISCUOUS: A database for network-based drug-repositioning","year":"2011-01-01"}],"summary":{"biotoolsCURIE":"biotools:promiscuous","biotoolsID":"promiscuous","description":"PROMISCUOUS is a database of drugs, including withdrawn or experimental drugs, annotated with drug-protein and protein-protein relationships compiled from public resources via text and data mining including manual curation. Measures of structural similarity for drugs as well as known side-effects can be easily connected to protein-protein interactions to establish and analyse networks responsible for multi-pharmacology.","homepage":"http://bioinformatics.charite.de/promiscuous","name":"PROMISCUOUS"}}